Albumin-induced apoptosis of tubular cells is modulated by BASP1

Cell Death and Disease

Volumn 6, Issue 2, 2015, Pages

  Sanchez Nino M D ^a,b   Fernandez, B ^b,c   Perez Gomez, M V ^b,c   Poveda, J ^b,c   Sanz, A B ^b,c   Cannata Ortiz, P ^b,c   Ruiz Ortega, M ^b,c   Egido, J ^c   Selgas, R ^a,b   Ortiz, A ^b,c,d  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b REDINREN   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALBUMIN; BRAIN ABUNDANT SIGNAL PROTEIN 1; MEMBRANE PROTEIN; MESSENGER RNA; PUROMYCIN AMINONUCLEOSIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALBUMINOID; BASP1 PROTEIN, HUMAN; BASP1 PROTEIN, RAT; CALMODULIN BINDING PROTEIN; CYTOSKELETON PROTEIN; NERVE PROTEIN; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NEPHROTIC SYNDROME; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; STAINING; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; MALE; METABOLISM; WESTERN BLOTTING;

RATTUS;

ALBUMINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALMODULIN-BINDING PROTEINS; CELL LINE; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; RATS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 84927590714     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.1     Document Type: Article

References (48)

1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150.
3. Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol 2012; 8: 301-306.
4. de Zeeuw D. The end of dual therapy with renin-angiotensin-aldosterone system blockade? N Engl J Med 2013; 369: 1960-1962.
5. Gutierrez E, Zamora I, Ballarin JA, Arce Y, Jimenez S, Quereda C et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 2012; 23: 1753-1760.
6. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545.
7. Garcia-Sanchez O, Lopez-Hernandez FJ, Lopez-Novoa JM. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int 2010; 77: 950-955.
8. Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression. Transplant Rev (Orlando ) 2012; 26: 3-13.
9. Zoja C, Benigni A, Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 2004; 13: 31-37.
10. Li X, Pabla N, Wei Q, Dong G, Messing RO, Wang CY et al. PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. J Am Soc Nephrol 2010; 21: 1115-1124.
11. Erkan E, De LM, Devarajan P. Albumin overload induces apoptosis in LLC-PK(1) cells. Am J Physiol Renal Physiol 2001; 280: F1107-F1114.
12. Ohse T, Inagi R, Tanaka T, Ota T, Miyata T, Kojima I et al. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int 2006; 70: 1447-1455.
13. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998; 53: 1608-1615.
14. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C et al. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 2002; 13: 1179-1189.
15. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733.
16. Tejera N, Gomez-Garre D, Lazaro A, Gallego-Delgado J, Alonso C, Blanco J et al. Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol 2004; 164: 1817-1826.
17. Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634-1642.
18. Bai L, Wang S. Targeting apoptosis pathways for new cancer therapeutics. Annu Rev Med 2013; 65: 139-155.
19. Sanchez-Nino MD, Sanz AB, Lorz C, Gnirke A, Rastaldi MP, Nair V et al. BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 610-621.
20. Maekawa S, Maekawa M, Hattori S, Nakamura S. Purification and molecular cloning of a novel acidic calmodulin binding protein from rat brain. J Biol Chem 1993; 268: 13703-13709.
21. Iino S, Taguchi K, Maekawa S, Nojyo Y. Motor, sensory and autonomic nerve terminals containing NAP-22 immunoreactivity in the rat muscle. Brain Res 2004; 1002: 142-150.
22. Mosevitsky MI, Capony JP, Skladchikova GY, Novitskaya VA, Plekhanov AY, Zakharov VV. The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. Biochimie 1997; 79: 373-384.
23. Justo P, Sanz AB, Sanchez-Nino MD, Winkles JA, Lorz C, Egido J et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 2006; 70: 1750-1758.
24. Ostroumova OS, Schagina LV, Mosevitsky MI, Zakharov VV. Ion channel activity of brain abundant protein BASP1 in planar lipid bilayers. FEBS J 2011; 278: 461-469.
25. Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI et al. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 2004; 24: 537-549.
26. Wiederkehr A, Staple J, Caroni P. The motility-associated proteins GAP-43, MARCKS, and CAP-23 share unique targeting and surface activity-inducing properties. Exp Cell Res 1997; 236: 103-116.
27. Park S, Kim YI, Kim B, Seong C, Oh Y, Baek K et al. Characterization of bovine and human cDNAs encoding NAP-22 (22 kDa neuronal tissue-enriched acidic protein) homologs. Mol Cells 1998; 8: 471-477.
28. Gagliardini V, Dusart I, Fankhauser C. Absence of GAP-43 can protect neurons from death. Mol Cell Neurosci 2000; 16: 27-33.
29. Zhao H, Cao Y, Grunz H. Isolation and characterization of a Xenopus gene (XMLP) encoding a MARCKS-like protein. Int J Dev Biol 2001; 45: 817-826.
30. Stocker KM, Ciment G, Baizer L. GAP-43 in non-neuronal cells of the embryonic chick limb: clues to function. Perspect Dev Neurobiol 1992; 1: 53-62.
31. Linkermann A, Brasen JH, Darding M, Jin MK, Sanz AB, Heller JO et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 2013; 110: 12024-12029.
32. Jin J, Ku YH, Kim Y, Kim Y, Kim K, Lee JY et al. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients. Exp Diabetes Res 2012; 2012: 168602.
33. Ju W, Greene CS, Eichinger F, Nair V, Hodgin JB, Bitzer M et al. Defining cell-type specificity at the transcriptional level in human disease. Genome Res 2013; 23: 1862-1873.
34. Green LM, Wagner KJ, Campbell HA, Addison K, Roberts SG. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation. Nucleic Acids Res 2009; 37: 431-440.
35. Toska E, Campbell HA, Shandilya J, Goodfellow SJ, Shore P, Medler KF et al. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep 2012; 2: 462-469.
36. Han MH, Jiao S, Jia JM, Chen Y, Chen CY, Gucek M et al. The novel caspase-3 substrate Gap43 is involved in AMPA receptor endocytosis and long-term depression. Mol Cell Proteomics 2013; 12: 3719-3731.
37. Kropotova E, Klementiev B, Mosevitsky M. BASP1 and its N-end fragments (BNEMFs) dynamics in rat brain during development. Neurochem Res 2013; 38: 1278-1284.
38. Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H et al. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Int J Oncol 2008; 33: 949-958.
39. Hartl M, Nist A, Khan MI, Valovka T, Bister K. Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1). Proc Natl Acad Sci U S A 2009; 106: 5604-5609.
40. Lin HY, Kuo YC, Weng YI, Lai IL, Huang TH, Lin SP et al. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent. Prostate 2012; 72: 1767-1778.
41. Dolcino M, Cozzani E, Riva S, Parodi A, Tinazzi E, Lunardi C et al. Gene expression profiling in dermatitis herpetiformis skin lesions. Clin Dev Immunol 2012; 2012: 198956.
42. Cremonesi P, Capoferri R, Pisoni G, Del CM, Strozzi F, Rupp R et al. Response of the goat mammary gland to infection with Staphylococcus aureus revealed by gene expression profiling in milk somatic and white blood cells. BMC Genomics 2012; 13: 540.
43. Wang Y, Sun Y, Wang H, Liu P, Peng W, Duan Y. Synthesis of low-molecular weight protein (LMWP) lysozyme-curcumin conjugates for kidney drug targeting. J Biomater Sci Polym Ed 2013; 24: 1360-1367.
44. Zhang Z, Zheng Q, Han J, Gao G, Liu J, Gong T et al. The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells. Biomaterials 2009; 30: 1372-1381.
45. Dolman ME, Fretz MM, Segers GJ, Lacombe M, Prakash J, Storm G et al. Renal targeting of kinase inhibitors. Int J Pharm 2008; 364: 249-257.
46. Sanchez-Nino MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, Saleem MA et al. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest 2012; 92: 32-45.
47. Sanchez-Nino MD, Poveda J, Sanz AB, Carrasco S, Ruiz-Ortega M, Selgas R et al. 3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes. Arch Toxicol 2013; 88: 597-608.
48. Gomez-Chiarri M, Ortiz A, Lerma JL, Lopez-Armada MJ, Mampaso F, Gonzalez E et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 1994; 70: 449-459.